{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:13Z","timestamp":1760188453634},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[1993,9,30]],"date-time":"1993-09-30T00:00:00Z","timestamp":749347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[1994,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>To determine whether patients with GSD\u20101 need nocturnal glucose therapy after completing physical growth and development, studies were performed on two consecutive nights. On the first night uncooked cornstarch (UCS) was given at the calculated glucose production rate at 21:00 h and 02:00 h. On the second night UCS was given at 21:00 h but omitted at 02:00 h. Six GSD\u20101 patients, aged 17.2\u201320.9 years, previously treated with continuous glucose therapy were studied. Measurements were made of plasma glucose (PG), serum insulin, growth hormone, cortisol, plasma glucagon (<jats:italic>n<\/jats:italic>=4), and blood lactate at 30\u201360\u2010min intervals. Serum uric acid, cholesterol, and triglycerides were measured at 21:00 h and 07:00 h, and serum FFA at 21:00 h, 02:00 h and 07:00 h on the first night and immediately before treatment for hypoglycaemia on the second night.<\/jats:p><jats:p>For five hours after UCS at 21:00 h, mean PG, serum insulin and blood lactate concentrations were similar on the two nights. With UCS at 02:00 h, mean PG concentrations were \u22654.1 mmol\/L from 02:00 to 07:00 h. Without UCS at 02:00 h, in all subjects PG concentrations fell to &lt;2.5 mmol\/L after 6.5\u20138.5 h and mean blood lactate concentration increased to 7.4\u00b13.0 mmol\/L.<\/jats:p><jats:p>Young adults with GSD\u20101 developed hypoglycaemia and hyperlactataemia after a relatively brief period without exogenous glucose and, therefore, need to continue nocturnal glucose therapy to prevent fasting hypoglycaemia.<\/jats:p>","DOI":"10.1007\/bf00711624","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T12:22:34Z","timestamp":1101817354000},"page":"234-241","source":"Crossref","is-referenced-by-count":16,"title":["Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease"],"prefix":"10.1002","volume":"17","author":[{"given":"J. I.","family":"Wolfsdorf","sequence":"first","affiliation":[{"name":"Department of Medicine (Division of Endocrinology) Children's Hospital  300 Longwood Ave Boston MA 02115 USA"},{"name":"Joslin Diabetes Center Harvard Medical School  Boston MA 02115 USA"},{"name":"Department of Pediatrics Harvard Medical School  Boston MA 02115 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"J. F.","family":"Crigler","sequence":"additional","affiliation":[{"name":"Department of Medicine (Division of Endocrinology) Children's Hospital  300 Longwood Ave Boston MA 02115 USA"},{"name":"Department of Pediatrics Harvard Medical School  Boston MA 02115 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1993,9,30]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.7.901"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-595X(82)80041-8"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.133"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.26.11.1016"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.4.12.2168325"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198401193100306"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801073180102"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/9780470720363.ch17","article-title":"Glycogen storage disease: new approaches to therapy","volume":"55","author":"Crigler JF","year":"1978","journal-title":"Hepatotrophic Factors. Ciba Found Symp"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-995"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-4-788"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197904000-00003"},{"key":"e_1_2_1_13_1","volume-title":"Recommended Dietary Allowances","author":"Food and Nutrition Board and the Subcommittee on the Tenth Edition of the RDAs","year":"1989"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197602192940805"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-3101(22)00671-5","article-title":"Type 1 glycogen storage disease: a metabolic basis for advances in treatment","volume":"26","author":"Greene HL","year":"1979","journal-title":"Adv Pediatr"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80270-3"},{"key":"e_1_2_1_17_1","first-page":"425","volume-title":"The Metabolic Basis of Inherited Disease","author":"Hers H\u2010G","year":"1989"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.2.223"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-58-4-654"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270140033019"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(81)90606-5"},{"key":"e_1_2_1_22_1","first-page":"192A","article-title":"Metabolic effects of glucose administration in adults with mild type 1 glycogen storage disease (abstract)","volume":"27","author":"Schwenk WF","year":"1990","journal-title":"Pediatr Res"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1093958"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.12.1597"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/52.6.1051"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/52.6.1043"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/56.3.587"},{"key":"e_1_2_1_28_1","first-page":"197A","article-title":"Determinants of renal dysfunction in type 1 glycogenosis (abstract)","volume":"33","author":"Wolfsdorf JI","year":"1993","journal-title":"Pediatr Res"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/BF00711624","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/BF00711624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T03:14:50Z","timestamp":1694747690000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/BF00711624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,9,30]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["10.1007\/BF00711624"],"URL":"https:\/\/doi.org\/10.1007\/bf00711624","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,9,30]]}}}